Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure
2016 · Journal of Intensive Care · 58 citations
https://doi.org/10.1186/s40560-016-0151-6
A
Anne Louise Kjølbye
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
1.3K
Citations
17
h-index
19
i10-index
Anne Louise Kjølbye is an academic researcher from Zealand Pharma (Denmark). The author has contributed to research in topics: Sepsis Diagnosis and Treatment & Cardiac electrophysiology and arrhythmias & Connexins and lens biology. The author has an h-index of 17, co-authored 24 publications.
Papers by this author
worksRationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock—Adaptive Clinical Trial
2018 · Annals of the American Thoracic Society · 44 citations
https://doi.org/10.1513/annalsats.201708-669sd
Lipidated IL-22 Alone or Combined with Immunomodulatory Agents Improves Disease Endpoints and Promotes Mucosal Healing in a Mouse Model of Chronic Dextran Sodium Sulfate-Induced Colitis
2025 · Digestive Diseases and Sciences · 1 citations
https://doi.org/10.1007/s10620-025-09007-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat